Idexx Laboratories (IDXX) Other financing activities (2009 - 2026)

Idexx Laboratories' Other financing activities history runs 18 years deep, the most recent figure standing at $18.2 million for Q1 2026.

• In Q1 2026, Other financing activities rose 152.48% year-over-year to $18.2 million; the TTM figure through Mar 2026 stood at $104.3 million (up 238.67% YoY), while the FY2025 annual figure was $93.4 million, up 109.84% from the prior year.
• Other financing activities for Q1 2026 stood at $18.2 million, up from $17.9 million in the prior quarter.
• The five-year high for Other financing activities was $51.0 million in Q3 2025, with the low at $4.9 million in Q3 2022.
• The 5-year median for Other financing activities is $12.5 million (2022), against an average of $14.0 million.
• Peak annual rise in Other financing activities reached 920.22% in 2025, while the deepest fall reached 65.55% in 2025.
• Idexx Laboratories' Other financing activities stood at $12.5 million in 2022, then fell by 9.29% to $11.3 million in 2023, then grew by 16.99% to $13.3 million in 2024, then jumped by 34.81% to $17.9 million in 2025, then grew by 1.63% to $18.2 million in 2026.
• Business Quant data shows IDXX's Other financing activities at $18.2 million in Q1 2026, $17.9 million in Q4 2025, and $51.0 million in Q3 2025.